News from the FDA/CDC


FDA approves first EpiPen generic

The approval is for the generic version of the most widely prescribed epinephrine autoinjector in the United States.

News from the FDA/CDC

FDA gives Orkambi indication for younger patients

Previously, the drug was indicated for certain cystic fibrosis patients aged 6 years and older, but now it is available for patients as young as 2...